Status:
COMPLETED
19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)
Lead Sponsor:
Geisinger Clinic
Conditions:
Chronic Liver Disease
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
To determine the adequacy of EUS-LB using a 19G core needle compared to a 22G core needle in a prospective randomized study.
Detailed Description
The 19Gauge core and 22Gauge core needles have both been used for EUS-LB with good success. Previous studies have reported good safety and tissue adequacy with both the needles, but the head-on compar...
Eligibility Criteria
Inclusion
- Patients undergoing EUS-LB
- Platelet Count \> 50,000
- International normalized ratio (INR) \< 1.5
- Age \> 18 years of age
- Non-Pregnant Patients
Exclusion
- Age \< 18 Years of Age
- Pregnant Patients
- Inability to obtain consent
- Anticoagulants or anti-platelet agents (excluding aspirin) within the last 7 -10 days
- Platelet count \< 50,000
- Presence of Ascites
- Known Liver Cirrhosis
Key Trial Info
Start Date :
April 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04806607
Start Date
April 30 2021
End Date
March 16 2022
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Medical Center
Danville, Pennsylvania, United States, 17822